Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin add-on therapy for refractory obsessive-compulsive disorder
IRCT2016041527392N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in obsessive compulsive disorder (OCD), sponsored by Isfahan University of Medical Sciences. Started Sep 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2016041527392N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016041527392N1.